AIEOP shared a post on LinkedIn:
“St. Jude Children’s Research Hospital Cancer Predisposition Symposium – ‘At the Crossroads: Intersection of Germline Predisposition and Pediatric Oncology Clinical Care and Research’
Date: October 14-15, 2025
Key topics to be discussed include:
- Advanced Genomic Sequencing: Development and implementation of sophisticated clinical genomic sequencing approaches for diagnosing hereditary cancer predisposition syndromes.
- Precision Medicine: Use of organ-sparing surgeries, molecularly targeted therapies, and innovative radiosurgery techniques for cancer treatment in children with genetic predisposition.
- Ethical Considerations: Exploration of the complex ethical and psychological dimensions surrounding germline genetic testing for hereditary cancer risk.
- Enhanced Survivorship: Development of specialized tools, genomic predictors, and transition-of-care programs to optimize long-term outcomes for young adults with cancer predisposition.
- Increasing Access: Fostering establishment of advanced practices to increase access and decrease disparities surrounding germline genetic testing for cancer predisposition.
More posts featuring AIEOP.